Cell Based Assays Market to be dominated by Assay Kits through 2028
Increasing number of drug discoveries is expected to drive the
growth of global Cell Based Assays in the forecast period, 2024-2028.
According to TechSci Research report, “Cell Based Assays Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”,
the global cell-based assays market is
anticipated to grow at an impressive rate in the forecast period 2024-2028. This
can be ascribed to the increasing demand for identification and optimization
procedures in drug development along with the rapid adoption of cell-based
assays by biopharmaceutical companies across the globe. Additionally, technological
advancements in the end users for cell-based assays and introduction of new
drugs especially in the developed countries in the North America and Europe,
altogether, are expected to create lucrative opportunities for the market
growth in the coming years. Besides, increasing investment for research and
demand for manufacturing of cell-based assay products in underdeveloped and
developing countries are further expected to support the market growth. Similarly,
in biomedical research screening for biological activity and biochemical
mechanisms, and off-target interactions for a molecule is anticipated to boost
the market growth during the forecasted year. Also, many private firms offer
customized assays that suit individual research need a focus on a therapeutic
regime to combat a particular disease which will further drive the market
growth during the forecasted years.
However, increasing
usage of expensive systems and high price of the instruments often reduce the
return on investment, thereby creating low adoption, consequently, slowing down
the growth of global cell-based assays market in the forecast period. Similarly, a dearth
of suitable professionals may hamper the cell-based assays market growth during the forecast period. Also, the
lack of awareness about new assays for the research and development in emerging
countries can further restrict the growth of global cell-based assays market.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Cell Based Assays Market"
The global cell-based assays market can be segmented by products and services,
by application, by end user and by region. Based on
products and services, the global cell-based
assays market can be segmented into Reagents,
Assay Kits, Microplates, Probes & Labels, Cell Lines, Others.
The assay and kits segment dominated the market in 2022 and is expected to
continue maintaining its dominance throughout the forecast period. This can be
ascribed to increasing usage in biopharmaceutical companies for drug
development across the globe.
Based on application, the market can be
segmented into Clinical Research, Drug Discovery & Development, Others. The drug discovery and development segment is
expected to dominate during the forecast period on account of increasing demand
for novel therapeutic drugs for the treatment of different kind of diseases
across the globe.
Major companies operating in global cell-based assays market are:
- Corning, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Lonza Group AG
- Promega Corporation
- F. Hoffmann-La Roche AG
- Merck KGaA
- Charles River Laboratories
International, Inc.
- Menarini Silicon Biosystems,
Inc.
For instance, in February 2020, Eurofins DiscoverX,
the products company of Eurofins Discovery announced their partnership with
VelaLabs of Vienna, Austria, in which Eurofins DiscoverX is granting the status
of Bioassay Certified CRO to VelaLabs as a certified provider of PathHunter
assay services.
In June 2020, PhenoVista Biosciences collaborated
with Olympus to deliver 3D cell-based assay services for drug discovery.
For instance, in March 2022, Promega Corporation
Collaborated with the FUJIFILM cellular dynamics to create novel assays to
observe cellular biology in a system that better reflects how cells behave in
the human body.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North America is
expected to dominate in the Global Cell Based Assays market due to the increasing
research and development activities in different research institutes
collaboratively sponsored by academic grants and biopharmaceutical grants
across the region. Similarly, the growing prevalence of lifestyle disorders
such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, and others
is expected to drive the growth of the market during the forecast period. Also,
growing demand for drug testing such as toxicity studies, drug screening, in
vitro screening, in vitro testing and others are also a major factor fueling
the growth of the market. Furthermore, increasing development of healthcare
expenditure and growing favorable reimbursement policies for the different
diseases treatment are further contributing to the demand for cell-based assays.
Besides, increasing investment by government organizations for development of
new cell-based assays in the region is further expected to create lucrative
opportunities for the market growth” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Cell Based Assays Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F Segmented By Products & Services (Reagents, Assay Kits,
Microplates, Probes & Labels, Cell Lines, Others), By Application (Clinical
Research, Drug Discovery & Development, Others), By End User (Biotechnology
& Pharmaceutical Companies, Academic & Research Institutions, Contract
Research Organizations), By
Region and Competition”, has evaluated
the future growth potential of global cell-based assays market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global cell-based assays market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com